Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer
Clinical trial NCT06492447 · UNKNOWN
Trial details
- NCT number
- NCT06492447
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-04
- Primary completion
- 2026-01-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.